Whistleblower in Tamiflu Case Alleges Pharmaceutical Company Fooled CDC into $1.4 Billion Contract. Exposing Misconduct.

Whistleblower in Tamiflu Case Alleges Pharmaceutical Company Fooled CDC into $1.4 Billion Contract

July 8, 2020

The pharmaceutical company Hoffmann-La Roche allegedly defrauded the federal government out of $1.4 billion by falsely representing claims of the drug Tamiflu’s effectiveness and potential in a pandemic, according to a False Claims Act whistleblower lawsuit unsealed in September of 2019.

Responding to La Roche’s motion to dismiss the lawsuit, the whistleblower, Dr. Thomas Jefferson, alleged that the company knew Tamiflu didn’t reduce the contagiousness of influenza or prevent people from contracting it. Studies show that Tamiflu reduces the duration of symptoms by half a day on average but does not stop the flu from spreading to others during that period. This effect may increase the overall contagiousness of influenza as asymptomatic people may still be contagious.

Read more here.
The materials on this website are for general information purposes only and should not be construed as legal advice, legal opinion or any other advice on any specific facts or circumstances. Readers should not act or refrain from acting upon this information without seeking professional advice. Transmission of information on or by use of this website is not intended to create, and receipt does not constitute, a lawyer-client relationship between the sender and receiver.
Mobile Menu
×